These staging systems are mainly based on some biochemical indicators (serum β2 microglobulin ≥ 5.5 mg/L, hypercalcemia, and so forth), bone damage (progressive osteolytic lesions, and so forth), and iFISH detection. The gene discussed is HLA-G; the disease is Hypercalcemia.